St. Louis MO 转移性癌症临床试验
54项针对 转移性癌症的研究正在 St. Louis及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
招募中3 期
- University of Kansas Cancer Center - Overland Park, Overland · 距离 10 英里
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
招募中2/3 期
- Washington University School of Medicine in St. Louis, St Louis
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- 以及另外 6 项
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- Washington University Medicine, St Louis
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
招募中1 期
- Washington University School of Medicine, St Louis
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- Washington University School of Medicine in St. Louis, St Louis
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
招募中1 期
- Washington University School of Medicine, St Louis
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
招募中1 期
- Washington University School of Medicine, St Louis
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
招募中1/2 期
- Washington University in St. Louis, St Louis
A Study of ASP3082 in Adults With Advanced Solid Tumors
招募中1 期
- Washington University School of Medicine, St Louis
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
招募中2/3 期
- Siteman Cancer Center, St Louis
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
招募中3 期
- Research Site, St Louis
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
招募中1/2 期
- Washington University School of Medicine in St. Louis, St Louis
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
招募中2/3 期
- Cancer Care Specialists of Illinois - Cancer Care Center of O'Fallon, O'Fallon · 距离 16 英里
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
招募中2 期
- Washington University School of Medicine- Siteman Cancer Center, St Louis
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
招募中1/2 期
- Washington University School of Medicine, St Louis
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
招募中3 期
- Washington University School of Medicine, St Louis
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
招募中1 期
- Washington University, St Louis
SLV-154 Treatment of Advanced Cancers
招募中1 期
- Washington University, St Louis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
招募中1/2 期
- Washington University, St Louis
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
招募中2 期
- Siteman Cancer Center (Washington University School of Medicine), St Louis
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
招募中1/2 期
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- 以及另外 5 项
A Study of KK2269 in Adult Participants With Solid Tumors
招募中1 期
- Washington University, St Louis
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
招募中1 期
- Washington University School of Medicine, St Louis
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
招募中1 期
- Siteman Cancer Center at Washington University, St Louis
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
招募中2 期
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- 以及另外 1 项
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
招募中1 期
- Washington University, St Louis
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
招募中1 期
- Washington University in St. Louis, St Louis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- Washington University School of Medicine, St Louis
IDOV-Immune for Advanced Solid Tumors
招募中1 期
- Washington University School of Medicine, St Louis
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
招募中1/2 期
- Washington University, St Louis
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
招募中1 期
- Investigative Site #110, St Louis
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
招募中1 期
- Investigative Site #110, St Louis
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
招募中1/2 期
- Washington University, St Louis
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
招募中1 期
- Washington University School of Medicine, St Louis
A Study of PYX-201 in Advanced Solid Tumors
招募中1 期
- Washington University School of Medicine, St Louis
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
招募中1 期
- Exelixis Clinical Site #6, St Louis
A Study of LY4175408 in Participants With Advanced Cancer
招募中1 期
- Washington University, St Louis
REMASTer: REcurrent Brain Metastases After SRS Trial
招募中
- WashU, St Louis
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
招募中3 期
- Washington University, St Louis
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
招募中2 期
- VA St. Louis Health Care System, St Louis
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
招募中1 期
- Research Site, St Louis
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
招募中1 期
- Research Site, St Louis
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
招募中1/2 期
- Washington University School of Medicine Siteman Cancer Center, St Louis
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
招募中3 期
- Washington University School of Medicine in Saint Louis, St Louis
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
招募中1 期
- Washington University School of Medicine, St Louis
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
招募中1/2 期
- Washington University School of Medicine, St Louis
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
招募中3 期
- Siteman Cancer Center - Washington University, St Louis
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
招募中观察性研究
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
招募中1 期
- Washington University, St Louis
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- Washington University, St Louis
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
招募中3 期
- The Washington University, St Louis
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
招募中1 期
- Washington University Medical Campus, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, St Louis
其他城市的 转移性癌症试验
- Houston, TX104 项研究
- New York City, NY93 项研究
- Nashville, TN70 项研究
- Boston, MA63 项研究
- Los Angeles, CA57 项研究
- Arlington, VA53 项研究
- Philadelphia, PA46 项研究
- Chicago, IL45 项研究
- San Antonio, TX44 项研究
- Washington, DC43 项研究
- Dallas, TX42 项研究
- Seattle, WA39 项研究
St. Louis的其他研究
- 非小细胞肺癌73 项研究
- 乳腺癌65 项研究
- 结直肠癌51 项研究
- 癌症（所有类型）47 项研究
- 前列腺癌46 项研究
- 肺癌39 项研究
- 卵巢癌38 项研究
- 胰腺癌33 项研究
- 子宫内膜癌29 项研究
- 头颈鳞状细胞癌28 项研究
- 心力衰竭26 项研究
- 肥胖症25 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月7日。每项研究自行设定入选标准，由研究团队决定谁能参与。